Rite Aid

Rite Aid Corp. engages in the ownership and management of retail drug stores. It operates through following segments: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment includes branded and generic prescription drugs, health and beauty aids, personal care products, and walk-in retail clinics. The Pharmacy Services segment offers transparent and traditional pharmacy benefit management for insurance companies, employers, health plans, and government employee groups. The company was founded by Alex Grass on September 12, 1962 and is headquartered in Philadelphia, PA.

Earnings data Q1 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Rite Aid is a drugstore chain that offers prescription medications, over-the-counter drugs, and health and wellness products. Rite Aid is reshaping the concept of a modern pharmacy by catering to customer demands through various convenient channels, including retail and delivery pharmacy services. Additionally, the company's offerings extend to services provided by its wholly-owned subsidiaries, namely Elixir, Bartell Drugs, and Health Dialog. Elixir, Rite Aid’s pharmacy benefits and services company, encompasses accredited mail and specialty pharmacies, prescription discount programs, and an advanced adjudication platform. These components combine to provide exceptional member experiences and substantial cost savings. Furthermore, Health Dialog delivers healthcare coaching and disease management services through interactive live online sessions and phone-based health services.

Rite Aid is a health products and services company with 2,400 locations across 17 states.

The company's omnichannel business includes digital, retail, and delivery touchpoints. Rite Aid is a top 20 seller of speciality medications, per its investor website.

In addition to its retail business, Rite Aid owns a pharmacy benefits subdivision (Elixir) and a personalized health services and coaching arm, Health Dialog, which has served 10MM members as of May 2022.

The company has reported $1.85 billion of liquidity with no debt maturities until 2025. According to its investor website, Rite Aid expects to be free cash flow (FCF) positive in FY23.

In Q2 2022, Rite Aid shared a three-part growth strategy aimed at deepening market share, expanding into new markets, and creating new offerings.

To grow the current business, Rite Aid is aiming to increase its e-commerce and digital sales, refresh its loyalty program, and grow its specialty pharmacy offering, which focuses on serving customers with complex health conditions.

New market expansion plans include increasing Rite Aid's footprint of "small format" pharmacies in underserved communities and implementing "store within a store" partnerships.

Rite Aid also aims to grow via new offerings, such as expanded health plan and health system clinical services, a pharmacy benefit manager (PBM) as a service offering, and new strategic partnerships.

Rite Aid Investor Relations

*This is not investment advice.

The drugstore chain named board member Elizabeth Burr as interim CEO as it looks for a permanent successor.

Rite Aid CEO Heyward Donigan Leaves

Rite Aid Corp. RAD, +0.29% said Monday its board has named Elizabeth Burr, a former Humana Inc. HUM, +0.93% executive, as interim chief executive, replacing Heyward Donigan, who is leaving the role. Burr was previously vice president, head of health ventures and chief innovation officer at Humana.

Rite Aid names ex-Humana exec Elizabeth Burr as interim CEO

Rite Aid said its chief executive officer Heyward Donigan is leaving the company, which has struggled to become profitable in her three-year reign.

Rite Aid CEO Donigan To Leave The Drugstore Chain

PHILADELPHIA--( BUSINESS WIRE )--Rite Aid Corporation (NYSE: RAD) (“Rite Aid” or the “Company”) announced today that its Board of Directors has appointed Elizabeth (“Busy”) Burr, a member of the Company's Board, as interim CEO, effective immediately. Burr's appointment follows Heyward Donigan's departure from the Company as President and CEO, and as a member of the Board. Rite Aid has initiated a search to identify a permanent CEO and has retained a leading executive search firm.

Rite Aid Corporation Names Elizabeth “Busy” Burr Interim Chief Executive Officer

Rite Aid's (RAD) Q3 results reflect the impacts of drab demand in flu immunizations and COVID-19 vaccines. Also, management updates its fiscal 2023 view.

Rite Aid (RAD) Q3 Loss Narrower Than Expected, Revenues Down

Rite Aid, which has already been closing unprofitable stores for the last year, may close even more, executives disclosed Wednesday.

Rite Aid Not Ruling Out More Store Closures

Rite Aid Corporation is on the cusp of bottoming and may already have its lowest price, if the institutions start buying again the stock could double.

Institutions Put Bottom In Rite Aid Shares

Why Rite Aid's Shares Dropped 17.3% on Wednesday

Rite Aid Corporation (NYSE:RAD ) Q3 2023 Results Conference Call December 21, 2022 8:30 AM ET Company Participants Byron Purcell - Vice President, Investor Relations and Treasurer Heyward Donigan - President & Chief Executive Officer Matt Schroeder - Executive Vice President and Chief Financial Officer Andre Persaud - Executive Vice President and Chief Retail Officer Chris DuPaul - Chief Operating Officer, Elixir Conference Call Participants Elizabeth Anderson - Evercore ISI George Hill - Deutsche Bank Lisa Gill - JPMorgan William Reuter - Bank of America Carla Casella - JPMorgan Karru Martinson - Jefferies Operator Good morning. My name is Rob, and I will be your conference operator today.

Rite Aid Corporation (RAD) Q3 2023 Earnings Call Transcript

Rite Aid Corp (NYSE: RAD), on Wednesday, said its net loss nearly doubled on a year-over-year basis in its third financial quarter. Rite Aid shares down on weak guidance Shares tanked almost 20% this morning to their all-time low after the pharmacy chain lowered its full-year guidance for the third time.

Rite Aid shares tank 20% to an all-time low: explore why

Rite Aid (RAD) delivered earnings and revenue surprises of 56.25% and 2.46%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?

Rite Aid (RAD) Reports Q3 Loss, Tops Revenue Estimates

Rite Aid reported a quarterly loss of more than $67 million due in part to “a reduction in COVID vaccine and testing revenue.”

Rite Aid Loss Hits $67 Million As Covid Shots And Testing Decline

Rite Aid Corp. RAD, +8.09% shares rose 7.7% in premarket trades after the pharmacy chain posted a narrower-than-expected loss and beat its revenue target. Rite Aid said its third-quarter loss widened to $67.14 million, or $1.23 a share, from a loss of $36.06 million, or 67 cents a share, in the year-ago quarter.

Rite Aid shares rally in premarket on narrower-than-expected loss and revenue beat

PHILADELPHIA--( BUSINESS WIRE )--Rite Aid Corporation (NYSE: RAD) today reported operating results for its third fiscal quarter ended November 26, 2022.

Rite Aid Corporation Reports Fiscal 2023 Third Quarter Results

NEW YORK , Dec. 19, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), of the important December 19, 2022 lead plaintiff deadline. SO WHAT: If you purchased Rite Aid securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

RAD FINAL DEADLINE TODAY: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important December 19 Deadline in Securities Class Action - RAD

Carnival

At Monday's opening bell, stocks traded just slightly lower. Within an hour, the Nasdaq traded down by around 0.05%, the S&P 500 down less than 1%, and the Dow up about 0.3%.

Earnings Previews: Carnival, Rite Aid

New York, New York--(Newsfile Corp. - December 19, 2022) - Levi & Korsinsky, LLP notifies investors in Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) of a class action securities lawsuit.The lawsuit on behalf of Rite Aid investors has been commenced in the the United States District Court for the Eastern District of Pennsylvania.

Rite Aid Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before December 19, 2022 to Discuss Your Rights - RAD

Los Angeles, California--(Newsfile Corp. - December 19, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Rite Aid Corporation ("Rite Aid" or "the Company") (NYSE: RAD) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Rite Aid Corporation with Losses of $100,000 to Contact the Firm

NEW YORK , Dec. 19, 2022 /PRNewswire/ -- Attention Rite Aid Corporation ("Rite Aid") (NYSE: RAD) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between April 14, 2022 and September 28, 2022. If you suffered a loss on your investment in Rite Aid, contact us about potential recovery by using the link below.

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rite Aid Investors of a Lead Plaintiff Deadline of December 19, 2022

New York, New York--(Newsfile Corp. - December 17, 2022) - Pomerantz LLP announces that a class action lawsuit has been filed against Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) and certain of its officers.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Rite Aid Corporation of Class Action Lawsuit and Upcoming Deadline - RAD

BENSALEM, Pa.--( BUSINESS WIRE )--Law Offices of Howard G. Smith announces an investigation on behalf of Rite Aid Corporation (“Rite Aid” or the “Company”) (NYSE: RAD) investors concerning the Company's possible violations of federal securities laws.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Rite Aid Corporation (RAD) on Behalf of Investors

Higher non-COVID prescriptions, strength in PBM and the expansion of delivery services are likely to Rite Aid's (RAD) Q3 results amid sluggishness in the Retail Pharmacy and Pharmacy Services segments.

Here's How Rite Aid (RAD) is Placed Just Ahead of Q3 Earnings

New York, New York--(Newsfile Corp. - December 16, 2022) -  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Rite Aid Corporation (NYSE: RAD) between April 14, 2022 and September 28, 2022, both dates inclusive (the "Class Period"), of the important December 19, 2022 lead plaintiff deadline.

RAD FINAL DEADLINE NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important December 19 Deadline in Securities Class Action - RAD

NEW YORK--( BUSINESS WIRE )--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Rite Aid securities between April 14, 2022 and September 28, 2022, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm's site: www.bgandg.com/rad.

Final Deadline: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Rite Aid Corporation (RAD) Investors of Class Action Deadline and Encourages Investors to Contact the Firm

New York, New York--(Newsfile Corp. - December 16, 2022) - Levi & Korsinsky, LLP notifies investors in Rite Aid Corporation ("Rite Aid" or the "Company") (NYSE: RAD) of a class action securities lawsuit.The lawsuit on behalf of Rite Aid investors has been commenced in the the United States District Court for the Eastern District of Pennsylvania.

Rite Aid Class Action: Levi & Korsinsky Reminds Rite Aid Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of December 19, 2022 - RAD

News for Rite Aid Stock (RAD)